BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Debiopharm Group™’s Innovative Antibiotic Debio 1450 – Developed From Its Proprietary Plateform Fabiotics – Receives Qualified Infectious Disease Product (QIDP) Designation From The FDA

  September 4, 2014

   · 

  2 min read
• BioMidwest

  American Brain Tumor Association-Funded Research Of OLIG2 Inhibitors Continues To Show Promise

  September 4, 2014

   · 

  3 min read
• FDA

  EndoCross Receives CE Mark Approval For The ENABLER-C Coronary Catheter System For The Crossing Of Coronary Chronic Total Occlusions

  September 4, 2014

   · 

  1 min read
• Teva Pharmaceutical Industries Limited To Present At The Morgan Stanley Global Healthcare Conference

  September 4, 2014

   · 

  1 min read
• Deals

  Cellectis Announces The Closing Of The Sale Of Its Swedish Subsidiary Cellectis AB To Takara Bio

  September 4, 2014

   · 

  1 min read
• Pharm Country

  MetaStat To Present At The Aegis Capital Corp. 2014 Healthcare & Technology Conference On September 11

  September 4, 2014

   · 

  1 min read
• Pharm Country

  Inovio Pharmaceuticals To List On NASDAQ

  September 4, 2014

   · 

  4 min read
• BioMidwest

  RestorGenex To Present At Rodman & Renshaw Global Investment Conference

  September 4, 2014

   · 

  1 min read
• BioCapital

  2014 Biotechnology Industry Organization (BIO) Investor Forum Buzz Of BIO Winners Announced

  September 4, 2014

   · 

  1 min read
• Guided Therapeutics, Inc. To Present At Rodman & Renshaw 16th Annual Global Investment Conference On Wednesday, September 10th

  September 4, 2014

   · 

  1 min read